(Q72473957)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8196293%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

title

Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8196293%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference

B J Pereira

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8196293%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

L Shapiro

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8196293%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

A J King

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8196293%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

M E Falagas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8196293%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

J A Strom

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8196293%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

C A Dinarello

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8196293%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

language of work or name

English

0 references

publication date

1 March 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8196293%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8196293%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8196293%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8196293%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

page(s)

890-896

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8196293%20AND%20SRC:MED&resulttype=core&format=json

Interleukin-1 activation and acute phase response during hemodialysis.

26 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

Cytokines: agents provocateurs in hemodialysis?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

Elevated circulating levels of interleukin-6 in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

Blood-membrane interaction in hemodialysis leads to increased cytokine production

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

Induction of tumor necrosis factor during extracorporeal blood purification

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

Tumour necrosis factor does not increase during routine cuprophane haemodialysis in healthy well-nourished patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

Isolation and characterization of a tumor necrosis factor binding protein from urine

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

In vitro production of interleukin-1 receptor antagonist in chronic renal failure, CAPD and HD

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

High levels of circulating soluble receptors for tumor necrosis factor in hairy cell leukemia and type B chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

Elevated serum levels of soluble tumour necrosis factor receptors (sTNF-R) in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

Concentrations of immunoreactive human tumor necrosis factor alpha produced by human mononuclear cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

Detection of tumor necrosis factor soluble receptor p55 in blood samples from healthy and endotoxemic humans.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

Detection of circulating tumor necrosis factor after endotoxin administration.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

Circulating interleukin-1 beta and tumor necrosis factor-alpha concentrations after burn injury in humans

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

ELISA kits based on monoclonal antibodies do not measure total IL-1 beta synthesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

Plasma tumor necrosis factor soluble receptors in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

In vitro production of IL 1 beta, IL 1 alpha, TNF and IL2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

Gene expression of interleukin-1 beta during hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

Comparison of first use and reuse of cuprophan membranes on interleukin-1 receptor antagonist and interleukin-1 beta production by blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

Differences in the synthesis and kinetics of release of interleukin 1 alpha, interleukin 1 beta and tumor necrosis factor from human mononuclear cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.117

7 January 2021

Identifiers

DOI

10.1038/KI.1994.117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8196293%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference